Originally developed to treat type 2 diabetes, these medications have become widely used for weight loss and many people of reproductive age are now taking them
A target of 64-80 ounces of fluid daily is appropriate for most patients (with adjustments for heart failure or kidney disease), with modifications based on activity level, climate, and gastrointestinal losses
Several clinical trials have also shown that GLP-1s can reduce an inflammation marker in the bloodbut its still unclear how much of that improvement is the result of weight loss or an independent effect of the drugs
Identification of a prolonged action molecular GLP-1R agonist for the treatment of femoral defects
Comment ORYGN below and I'll send you the ingredient overview including the research references
Buyer Takeaway: GI side effects are common, especially early in treatment, and typically manageable